Table 4 Comparison with other studies’ outcomes
| Â | Present study | LUMIERE | LUMINOUS Germany (WAVE) | LUMINOUS Netherlands (HELIOS) | LUMINOUS Belgium (HELIOS) | LUMINOUS Sweden | RASMUNSEN |
|---|---|---|---|---|---|---|---|
Number injections 1st year | 3.9 ± 1.5 | 5.1 | 4.3 (±1.9) | 5.5 (±2.3) | 5.7 (±1.8) | 4.7 (±1.6) | 5.2 |
Number injections 4th year | 1.8 ± 3.1 |  |  |  |  |  | 6.4 |
Initial logMAR VA | O.8 | 0.86 (53.2 letters) | 0.98 (48.8 letters) | 1 (45.1 letters) | 0.92 (56.3 letters) | 0.76 (58.3 letters) | 0.6 (0.24 Snellen) |
1st year logMAR VA | 0.8 | 0.92 (gain 3.2 = 56.4 letters) | 0.96 (48.0 letters) | 1.02 (50.7 letters) | 0.78 (58.8 letters) | 0.78 (59.3 letters) | 0.5 (0.35 Snellen) |
Final logMAR VA (4th y) | 1 | Â | Â | Â | Â | Â | 0.8 (0.18 Snellen) |